A carregar...
A Sativex®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
BACKGROUND AND PURPOSE: Sativex® is an oromucosal spray, containing equivalent amounts of Δ(9)-tetrahydrocannabinol (Δ(9)-THC) and cannabidiol (CBD)-botanical drug substance (BDS), which has been approved for the treatment of spasticity and pain associated to multiple sclerosis (MS). In this study,...
Na minha lista:
| Publicado no: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4507161/ https://ncbi.nlm.nih.gov/pubmed/25857324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13159 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|